Meditation and Biofeedback to Improve Anxiety, Depression and Quality of Life in Inpatients After Stroke
Launched by SUNNYBROOK HEALTH SCIENCES CENTRE · May 4, 2023
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a technology-based meditation program can help inpatients who have recently had a stroke. The goal is to see if this meditation can reduce feelings of anxiety and depression and improve overall quality of life for these patients. If you are an adult who has had a stroke within the last two months and are at risk for depression or anxiety, you might be eligible to participate.
As a participant, you would be asked to take part in meditation therapy at least three times a week for at least 10 minutes each session. You will also use a special device to help monitor your heart rate and provide feedback on your meditation practice. While some participants will use this program, others will continue with standard care and complete surveys about their experience. The study also plans to gather more insights by talking to patients and staff about how meditation may benefit those recovering from a stroke.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult (18 years and older)
- • Inpatient rehabilitation patients at St. John's Rehab
- • Experienced a stroke within the past two months prior to study enrollment
- • Identified as being at risk for depression and/or anxiety based on their scores on study screening tools
- • Able to comply with study requirements
- Exclusion Criteria:
- • Younger than 18 years old
- • Significant comorbidity including psychiatric or neurological disorder (not including premorbid depression or anxiety)
- • Inability to complete any of the outcome measures
- • Starting a new antidepressant or a change in antidepressant medication within the past 6 months
- • Inability to provide informed consent
- • For qualitative interviews, patients can have experienced a stroke within one year.
- • For focus groups, staff who work significantly with stroke patients at St. John's Rehab. Staff can be physicians, nurses, allied health.
About Sunnybrook Health Sciences Centre
Sunnybrook Health Sciences Centre is a leading academic health science organization located in Toronto, Canada, renowned for its commitment to advancing patient care through innovative research and education. As a prominent clinical trial sponsor, Sunnybrook integrates cutting-edge medical research with clinical practice, focusing on a wide range of health disciplines, including cancer care, trauma, and cardiovascular health. The center collaborates with various stakeholders, including academic institutions, healthcare providers, and industry partners, to facilitate the development of novel therapies and improve health outcomes. With a robust infrastructure and a dedicated team of researchers and clinicians, Sunnybrook plays a pivotal role in translating scientific advancements into tangible benefits for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Trial Officials
Amanda Ratner, M.Sc.
Principal Investigator
Sunnybrook Health Sciences Centre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported